Skip to content
Clinical Trials – home
LatviaBack to Latvia

Clinical trials in Ogre

12 clinical trials in Ogre, Latvia. Every trial is listed in the EU Clinical Trials Register and updated daily.

LatviaOur site in LatviaKliniskiePetijumi.lv(opens in a new tab)
Ogre at a glance
12
clinical trials
  • Paediatric trials0
  • Research sites0
Type of trial
Recruitment status
Quick filters

12 trials in Ogre

Open in trial search
Countries:LatviaLatvia
  • Participants:18–64 years · 65+ years
  • Substances:Bi 690517
  • Sponsor:Boehringer Ingelheim Espana S.A.
Countries:LatviaLatvia
  • Participants:18–64 years · 65+ years
  • Substances:IMEROPRUBART
  • Sponsor:Immunovant Sciences GmbH
Countries:LatviaLatvia
  • Participants:18–64 years · 65+ years
  • Substances:Apixaban
  • Sponsor:Regeneron Pharmaceuticals Inc.
Countries:LatviaLatvia
  • Participants:18–64 years · 65+ years
  • Substances:Semaglutide
  • Sponsor:Novo Nordisk A/S
Countries:LatviaLatvia
  • Participants:18–64 years · 65+ years
  • Substances:Evolocumab
  • Sponsor:Amgen Inc.

Arteriosclerosis

Not recruiting
Registered drugNo placebo
Countries:LatviaLatvia
  • Participants:18–64 years · 65+ years
  • Substances:Inclisiran
  • Sponsor:Novartis Pharma AG
Countries:LatviaLatvia
  • Participants:18–64 years · 65+ years
  • Substances:Dapagliflozin
  • Sponsor:Institut De Recherches Internationales Servier IRIS
Countries:LatviaLatvia
  • Participants:18–64 years · 65+ years
  • Substances:Batoclimab
  • Sponsor:Immunovant Sciences GmbH
Countries:LatviaLatvia
  • Participants:18–64 years · 65+ years
  • Substances:Inclisiran
  • Sponsor:Novartis Pharma AG
Investigational
Countries:LatviaLatvia
  • Participants:18–64 years · 65+ years
  • Substances:Batoclimab
  • Sponsor:Immunovant Sciences GmbH
Countries:LatviaLatvia
  • Participants:18–64 years · 65+ years
  • Substances:Apixaban
  • Sponsor:Bayer AG

Other cities in Latvia

The busiest research cities in the country

All 19 cities in Latvia

Clinical research in Ogre

What the registry says about research in the country

01 Cardiovascular Research

Innovative studies focusing on stroke prevention and cardiovascular health management, particularly examining new therapeutic approaches for patients with atrial fibrillation and investigating treatments for atherosclerotic cardiovascular disease.

  • Atrial Fibrillation Management
  • ASCVD Prevention
  • Stroke Risk Reduction

Advanced research comparing different anticoagulation strategies and preventive treatments for cardiovascular events.

02 Endocrine Disorders

Comprehensive research into Type 2 Diabetes management and its complications, including studies on combination therapies and the impact of treatments on diabetic retinopathy.

  • Diabetes Management
  • Glycemic Control
  • Diabetic Eye Disease

Evaluating innovative treatment combinations and their effects on long-term diabetes complications.

03 Metabolic & Eye Conditions

Cutting-edge research addressing Thyroid Eye Disease and cholesterol management, exploring new therapeutic options for patients with challenging metabolic conditions.

  • Hypercholesterolemia Treatment
  • TED Management
  • Lipid Control

Investigation of novel treatments aimed at improving patient outcomes and quality of life.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.

Legal notice · Published by CTIN POLAND sp. z o.o., ul. rtm. Witolda Pileckiego 67/109, 02-781 Warsaw, Poland · KRS 0001111334 · REGON 528919042 · NIP 9512598637

© 2026 Clinical Trials EU – European Clinical Trials Information Network

GDPR compliance, ISO 9001 and ISO 27001 certified (LL-C Certification)

On this site, “treatment” means an investigational medicine being studied in a clinical trial. Its safety and efficacy for the use being studied have not yet been confirmed, some participants may receive a placebo or a comparator medicine, and taking part does not guarantee any health benefit. The decision to take part is made by the doctor at the research site. This site is for information only and does not replace medical advice.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic sites, national regulators and commercial sponsors. On this site, “treatment” and “therapy” mean a medicine being tested in a clinical trial. Its safety and effectiveness in the use being studied are not yet confirmed, some participants may receive a placebo or a comparator, and taking part does not guarantee a health benefit. The doctor at the research site decides who can take part. This site provides information, not medical advice. Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).